insights_auto
Why is ROIV up 3.30%?
Dive Deeperchevron_right
ROIV:NASDAQ
Roivant Sciences Ltd
$36.98
arrow_upward
+3.30%(+1.18) 1D
$37.20
arrow_upward
+0.59% (+0.22)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$35.65
High
$37.24
Low
$35.28
Mkt. cap
26.71B
Avg. vol.
9.04M
Volume
6.97M
52-wk high
$42.50
52-wk low
$14.86
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
Open
$35.65
High
$37.24
Low
$35.28
Mkt. cap
26.71B
Avg. vol.
9.04M
Volume
6.97M
52-wk high
$42.50
52-wk low
$14.86
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Investing.com Nigeria
·
15 hours ago
Form 4 Roivant Sciences Ltd. For: 28 September By Investing.com
Oligarch Watch
·
1 month ago
How Vivek Ramaswamy’s mom manipulated Alzheimer’s data and made her son rich
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd